Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Mirtazapine and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment of Post-traumatic Stress Disorder (PTSD)

NCT01178671 is registered in ClinicalTrials.gov with Research Foundation for Mental Hygiene, Inc. as lead sponsor.

NCT NCT01178671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01178671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Mirtazapine and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment of Post-traumatic Stress Disorder (PTSD)
Lead sponsor
Research Foundation for Mental Hygiene, Inc.
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2010
Completion date
June 30, 2014
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder